Liang Wei Wang Selected Research

Liang Wei Wang Research Topics

4	Infections 01/2022 - 09/2017
3	COVID-19 01/2022 - 01/2021
2	Neoplasms (Cancer) 01/2024 - 11/2017
1	Human Influenza (Influenza) 08/2021
1	Whooping Cough (Pertussis) 08/2021
1	Post-Acute COVID-19 Syndrome 01/2021
1	Nasopharyngeal Carcinoma 11/2017
1	Lymphoma (Lymphomas) 11/2017
1	Epstein-Barr Virus Infections 01/2017
1	Cytomegalovirus Infections (Inclusion Disease) 01/2017
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2017

2	CytokinesIBA 01/2022 - 01/2021
2	Immunoglobulin A (IgA)IBA 01/2022 - 01/2021
2	AntibodiesIBA 01/2022 - 08/2021
1	mRNA VaccinesIBA 01/2022
1	VaccinesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Messenger RNA (mRNA)IBA 08/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	CholesterolIBA 01/2019
1	CarbonIBA 01/2019
1	Viral ProteinsIBA 01/2019
1	Epstein-Barr virus EBV-associated membrane antigenIBA 11/2017
1	LuciferasesIBA 09/2017
1	Hepatitis B Core AntigensIBA 09/2017
1	pgRNAIBA 09/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Complement System Proteins (Complement)IBA 01/2017

1	Immunotherapy 01/2024